Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-06-09 @ 8:36 AM
Study NCT ID:
NCT01297920
Status:
COMPLETED
Last Update Posted:
2013-07-04
First Post:
2011-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-10-039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None